This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
moving-average-crossover: Archive
Boston Scientific (BSX) Recently Broke Out Above the 50-Day Moving Average
by Zacks Equity Research
Should investors be excited or worried when a stock crosses above the 50-Day simple moving average?
BSXPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Armata Pharmaceuticals (ARMP) Surges 103.2%: Is This an Indication of Further Gains?
by Zacks Equity Research
Armata Pharmaceuticals (ARMP) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
ARMPNegative Net Change NEONegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Innoviva (INVA): Can Its 5.5% Jump Turn into More Strength?
by Zacks Equity Research
Innoviva (INVA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
INVAPositive Net Change NVONegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
WidePoint (WYY) Soars 12.0%: Is Further Upside Left in the Stock?
by Zacks Equity Research
WidePoint (WYY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
WYYNegative Net Change PDFSNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
eGain (EGAN) Soars 6.0%: Is Further Upside Left in the Stock?
by Zacks Equity Research
eGain (EGAN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
EGANNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Gibraltar Industries (ROCK) Surges 5.4%: Is This an Indication of Further Gains?
by Zacks Equity Research
Gibraltar Industries (ROCK) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
ROCKNegative Net Change AGXNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Five Star Bancorp (FSBC): Can Its 5.1% Jump Turn into More Strength?
by Zacks Equity Research
Five Star Bancorp (FSBC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
FSBCPositive Net Change BOHPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
MeiraGTx (MGTX) Moves 12.4% Higher: Will This Strength Last?
by Zacks Equity Research
MeiraGTx (MGTX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
MGTXNegative Net Change URGNNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Arcturus Therapeutics (ARCT) Moves 7.7% Higher: Will This Strength Last?
by Zacks Equity Research
Arcturus Therapeutics (ARCT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
ARCTNegative Net Change SEPNNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Bally's (BALY) Moves 17.8% Higher: Will This Strength Last?
by Zacks Equity Research
Bally's (BALY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
BALYPositive Net Change GDEVPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today